Periodontal innate immune mechanisms relevant to atherosclerosis

Molecular Oral Microbiology

Volumn 30, Issue 3, 2015, Pages 171-185

  Amar, S ^a   Engelke, M ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Porphyromonas gingivalis; Atherosclerosis; Innate immunity; Nucleotide binding oligomerization domain 2; Toll like receptors

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; NOD2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ATHEROSCLEROSIS; BACTERIUM DETECTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOTHELIUM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; REVIEW; ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; MICROBIOLOGY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MICE; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84928678696     PISSN: 20411006     EISSN: 20411014     Source Type: Journal    
DOI: 10.1111/omi.12087     Document Type: Review

References (116)

1. Aderem, A. (2003) Phagocytosis and the inflammatory response. J Infect Dis 187(Suppl. 2): S340-S345.
2. Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
3. Amabile, N., Susini, G., Pettenati-Soubayroux, I. et al. (2008) Severity of periodontal disease correlates to inflammatory systemic status and independently predicts the presence and angiographic extent of stable coronary artery disease. J Intern Med 263: 644-652.
4. Amar, S., Gokce, N., Morgan, S., Loukideli, M., Van Dyke, T.E. and Vita, J.A. (2003) Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol 23: 1245-1249.
5. Amar, S., Wu, S.C. and Madan, M. (2009) Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J Immunol 182: 1584-1592.
6. Aoki, Y., Tabeta, K., Murakami, Y., Yoshimura, F. and Yamazaki, K. (2010) Analysis of immunostimulatory activity of Porphyromonas gingivalis fimbriae conferred by Toll-like receptor 2. Biochem Biophys Res Commun 398: 86-91.
7. Arbes, S.J. Jr, Slade, G.D. and Beck, J.D. (1999) Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78: 1777-1782.
8. Areschoug, T. and Gordon, S. (2008) Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands. Contrib Microbiol 15: 45-60.
9. Asai, Y., Ohyama, Y., Gen, K. and Ogawa, T. (2001) Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun 69: 7387-7395.
10. Bahekar, A.A., Singh, S., Saha, S., Molnar, J. and Arora, R. (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154: 830-837.
11. van Beelen, A.J., Zelinkova, Z., Taanman-Kueter, E.W. et al. (2007) Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669.
12. Beutler, B., Jiang, Z., Georgel, P. et al. (2006) Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 24: 353-389.
13. Biswas, S.K. and Lopez-Collazo, E. (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30: 475-487.
14. Blake, G.J. and Ridker, P.M. (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252: 283-294.
15. Borm, M.E., van Bodegraven, A.A., Mulder, C.J., Kraal, G. and Bouma, G. (2008) The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Genes Immun 9: 274-278.
16. Burns, E., Bachrach, G., Shapira, L. and Nussbaum, G. (2006) Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 177: 8296-8300.
17. Campus, G., Salem, A., Uzzau, S., Baldoni, E. and Tonolo, G. (2005) Diabetes and periodontal disease: a case-control study. J Periodontol 76: 418-425.
18. Cavrini, F., Sambri, V., Moter, A. et al. (2005) Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol 54: 93-96.
19. Chamaillard, M., Girardin, S.E., Viala, J. and Philpott, D.J. (2003a) Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5: 581-592.
20. Chamaillard, M., Hashimoto, M., Horie, Y. et al. (2003b) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4: 702-707.
21. Chi, H., Messas, E., Levine, R.A., Graves, D.T. and Amar, S. (2004) Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 110: 1678-1685.
22. Chiang, C.Y., Kyritsis, G., Graves, D.T. and Amar, S. (1999) Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67: 4231-4236.
23. Cohen, J. (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
24. Costalonga, M., Batas, L. and Reich, B.J. (2009) Effects of Toll-like receptor 4 on Porphyromonas gingivalis-induced bone loss in mice. J Periodontal Res 44: 537-542.
25. Cullinan, M.P., Hamlet, S.M., Westerman, B., Palmer, J.E., Faddy, M.J. and Seymour, G.J. (2003) Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice. J Clin Periodontol 30: 532-541.
26. Dasanayake, A.P. (2009) C-reactive protein levels are elevated in patients with periodontitis and their CRP levels may go down after periodontal therapy. J Evid Based Dent Pract 9: 21-22.
27. Dasanayake, A.P., Boyd, D., Madianos, P.N., Offenbacher, S. and Hills, E. (2001) The association between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight. J Periodontol 72: 1491-1497.
28. Dasanayake, A.P., Russell, S., Boyd, D., Madianos, P.N., Forster, T. and Hill, E. (2003) Preterm low birth weight and periodontal disease among African Americans. Dent Clin North Am 47: 115-125, x-xi.
29. den Dekker, W.K., Cheng, C., Pasterkamp, G. and Duckers, H.J. (2010) Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209: 314-320.
30. Deshpande, R.G., Khan, M.B. and Genco, C.A. (1998) Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 66: 5337-5343.
31. DeStefano, F., Anda, R.F., Kahn, H.S., Williamson, D.F. and Russell, C.M. (1993) Dental disease and risk of coronary heart disease and mortality. BMJ 306: 688-691.
32. Dobrovolskaia, M.A., Medvedev, A.E., Thomas, K.E. et al. (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170: 508-519.
33. Emingil, G., Atilla, G. and Huseyinov, A. (2004) Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 31: 829-834.
34. Epstein, S.E. (2002) The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 90: 2-4.
35. Epstein, S.E., Zhou, Y.F. and Zhu, J. (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20-e28.
36. Foey, A.D. and Crean, S. (2013) Macrophage subset sensitivity to endotoxin tolerisation by Porphyromonas gingivalis. PLoS One 8: e67955.
37. Geivelis, M., Turner, D.W., Pederson, E.D. and Lamberts, B.L. (1993) Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 64: 980-983.
38. Gibson, F.C. 3rd, Hong, C., Chou, H.H. et al. (2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109: 2801-2806.
39. Girardin, S.E., Tournebize, R., Mavris, M. et al. (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2: 736-742.
40. Girardin, S.E., Hugot, J.P. and Sansonetti, P.J. (2003a) Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 24: 652-658.
41. Girardin, S.E., Boneca, I.G., Carneiro, L.A. et al. (2003b) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587.
42. Girardin, S.E., Boneca, I.G., Viala, J. et al. (2003c) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872.
43. Haraszthy, V.I., Zambon, J.J., Trevisan, M., Zeid, M. and Genco, R.J. (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 1554-1560.
44. Hayashi, C., Madrigal, A.G., Liu, X. et al. (2010) Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J Innate Immun 2: 334-343.
45. Heitman, J. (2006) Sexual reproduction and the evolution of microbial pathogens. Curr Biol 16: R711-R725.
46. Hirao, K., Yumoto, H., Takahashi, K., Mukai, K., Nakanishi, T. and Matsuo, T. (2009) Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res 88: 762-767.
47. Hoge, M. and Amar, S. (2006) Role of interleukin-1 in bacterial atherogenesis. Drugs Today (Barc) 42: 683-688.
48. Hosokawa, I., Hosokawa, Y., Ozaki, K., Yumoto, H., Nakae, H. and Matsuo, T. (2010) Proinflammatory effects of muramyldipeptide on human gingival fibroblasts. J Periodontal Res 45: 193-199.
49. Hou, L., Sasaki, H. and Stashenko, P. (2000) Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infect Immun 68: 4681-4687.
50. Hugot, J.P., Chamaillard, M., Zouali, H. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
51. Inohara, N., Ogura, Y., Chen, F.F., Muto, A. and Nunez, G. (2001) Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276: 2551-2554.
52. Inohara, N., Chamaillard, M., McDonald, C. and Nunez, G. (2005) NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74: 355-383.
53. Jerala, R. (2007) Structural biology of the LPS recognition. Int J Med Microbiol 297: 353-363.
54. Jo, E.K. (2008) Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis, 21: 279-286.
55. Johannsen, L., Wecke, J., Obal, F. Jr and Krueger, J.M. (1991) Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am J Physiol 260: R126-R133.
56. Johansson, M.E., Zhang, X.Y., Edfeldt, K. et al. (2014) Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur J Immunol 44: 3081-3092.
57. Johnson, L.L. and Sayles, P.C. (2002) Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun 70: 185-191.
58. Johnson, J.D., O'Connor, K.A., Deak, T., Stark, M., Watkins, L.R. and Maier, S.F. (2002) Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun 16: 461-476.
59. Joshipura, K.J., Rimm, E.B., Douglas, C.W., Trichopoulos, D., Ascherio, A. and Willett, W.C. (1996) Poor oral health and coronary heart disease. J Dent Res 75: 1631-1636.
60. Juarez, E., Carranza, C., Hernandez-Sanchez, F. et al. (2012) NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans. Eur J Immunol 42: 880-889.
61. Khlgatian, M., Nassar, H., Chou, H.H., Gibson, F.C. 3rd and Genco, C.A. (2002) Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70: 257-267.
62. Kim, J. and Amar, S. (2006) Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 94: 10-21.
63. Kim, Y.G., Park, J.H., Shaw, M.H., Franchi, L., Inohara, N. and Nunez, G. (2008) The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28: 246-257.
64. Lesage, S., Zouali, H., Cezard, J.P. et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70: 845-857.
65. Liu, H.Q., Zhang, X.Y., Edfeldt, K. et al. (2013) NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb Vasc Biol 33: 2193-2201.
66. Liu, J., Wang, Y. and Ouyang, X. (2014) Beyond toll-like receptors: Porphyromonas gingivalis induces IL-6, IL-8, and VCAM-1 expression through NOD-mediated NF-kappaB and ERK signaling pathways in periodontal fibroblasts. Inflammation 37: 522-533.
67. Loppnow, H. (2008) Intited review: vascular cells control atherosclerosis by cytokine- and innate immunity-related inflammatory mechanisms. Innate Immun 14: 63-68.
68. Loppnow, H., Werdan, K. and Buerke, M. (2008) Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun 14: 63-87.
69. Madan, M. and Amar, S. (2008) Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS One 3: e3204.
70. Mahmoudi, M., Curzen, N. and Gallagher, P.J. (2007) Atherogenesis: the role of inflammation and infection. Histopathology 50: 535-546.
71. Martin, S.A., Karnovsky, M.L., Krueger, J.M., Pappenheimer, J.R. and Biemann, K. (1984) Peptidoglycans as promoters of slow-wave sleep I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem 259: 12652-12658.
72. Mattila, K.J. (1989) Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 225: 293-296.
73. Mattila, K.J. (1993) Dental infections as a risk factor for acute myocardial infarction. Eur Heart J 14(Suppl. K): 51-53.
74. Mattila, K.J., Valtonen, V.V., Nieminen, M. and Huttunen, J.K. (1995) Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 20: 588-592.
75. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
76. Medzhitov, R. and Janeway, C. Jr (2000) Innate immune recognition: mechanisms and pathways. Immunol Rev 173: 89-97.
77. Michalowicz, B.S., Diehl, S.R., Gunsolley, J.C. et al. (2000) Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 71: 1699-1707.
78. Michelsen, K.S., Doherty, T.M., Shah, P.K. and Arditi, M. (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173: 5901-5907.
79. Moreira, L.O. and Zamboni, D.S. (2012) NOD1 and NOD2 signaling in infection and inflammation. Front Immunol 3: 328.
80. Murray, P.J. (2005) NOD proteins: an intracellular pathogen-recognition system or signal transduction modifiers? Curr Opin Immunol 17: 352-358.
81. Muthukuru, M., Jotwani, R. and Cutler, C.W. (2005) Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect Immun 73: 687-694.
82. Nakajima, T., Honda, T., Domon, H. et al. (2010) Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 45: 116-122.
83. Nery, E.B., Meister, F. Jr, Ellinger, R.F., Eslami, A. and McNamara, T.J. (1987) Prevalence of medical problems in periodontal patients obtained from three different populations. J Periodontol 58: 564-568.
84. Nishimura, F., Taniguchi, A., Yamaguchi-Morimoto, M. et al. (2006) Periodontal infection and dyslipidemia in type 2 diabetics: association with increased HMG-CoA reductase expression. Horm Metab Res 38: 530-535.
85. Njoroge, T., Genco, R.J., Sojar, H.T., Hamada, N. and Genco, C.A. (1997) A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun 65: 1980-1984.
86. Ogura, Y., Bonen, D.K., Inohara, N. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
87. Oh, H.M., Lee, H.J., Seo, G.S. et al. (2005) Induction and localization of NOD2 protein in human endothelial cells. Cell Immunol 237: 37-44.
88. Ohki, T., Itabashi, Y., Kohno, T. et al. (2012) Detection of periodontal bacteria in thrombi of patients with acute myocardial infarction by polymerase chain reaction. Am Heart J 163: 164-167.
89. Park, J.H., Kim, Y.G., Shaw, M. et al. (2007) Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 179: 514-521.
90. Progulske-Fox, A., Kozarov, E., Dorn, B., Dunn, W. Jr, Burks, J. and Wu, Y. (1999) Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system. J Periodontal Res 34: 393-399.
91. Pussinen, P.J., Vilkuna-Rautiainen, T., Alfthan, G. et al. (2004) Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol 24: 2174-2180.
92. Raetz, C.R. (1990) Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170.
93. Rath, S.K., Mukherjee, M., Kaushik, R., Sen, S. and Kumar, M. (2014) Periodontal pathogens in atheromatous plaque. Indian J Pathol Microbiol 57: 259-264.
94. Ren, L., Leung, W.K., Darveau, R.P. and Jin, L. (2005) The expression profile of lipopolysaccharide-binding protein, membrane-bound CD14, and toll-like receptors 2 and 4 in chronic periodontitis. J Periodontol 76: 1950-1959.
95. Salvi, G.E., Brown, C.E., Fujihashi, K. et al. (1998) Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 33: 212-225.
96. Salzberg, T.N., Overstreet, B.T., Rogers, J.D., Califano, J.V., Best, A.M. and Schenkein, H.A. (2006) C-reactive protein levels in patients with aggressive periodontitis. J Periodontol 77: 933-939.
97. Slots, J. and Genco, R.J. (1984) Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res 63: 412-421.
98. Stroh, T., Batra, A., Glauben, R. et al. (2008) Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. J Immunol 181: 3620-3627.
99. Sugawara, Y., Uehara, A., Fujimoto, Y. et al. (2006) Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 85: 524-529.
100. Sun, X.J., Meng, H.X., Shi, D. et al. (2009) Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis. J Periodontal Res 44: 311-316.
101. Tanabe, S.I. and Grenier, D. (2008) Macrophage tolerance response to Aggregatibacter actinomycetemcomitans lipopolysaccharide induces differential regulation of tumor necrosis factor-alpha, interleukin-1 beta and matrix metalloproteinase 9 secretion. J Periodontal Res 43: 372-377.
102. Tang, K., Lin, M., Wu, Y. and Yan, F. (2011a) Alterations of serum lipid and inflammatory cytokine profiles in patients with coronary heart disease and chronic periodontitis: a pilot study. J Int Med Res 39: 238-248.
103. Tang, L., Zhou, X.D., Wang, Q. et al. (2011b) Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts. Arch Oral Biol 56: 1064-1072.
104. Tonetti, M.S., D'Aiuto, F., Nibali, L. et al. (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356: 911-920.
105. Tsai, C.C., Ho, Y.P. and Chen, C.C. (1995) Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 66: 852-859.
106. Umino, M. and Nagao, M. (1993) Systemic diseases in elderly dental patients. Int Dent J 43: 213-218.
107. Van Dyke, T.E. and Sheilesh, D. (2005) Risk factors for periodontitis. J Int Acad Periodontol 7: 3-7.
108. Velsko, I.M., Chukkapalli, S.S., Rivera, M.F. et al. (2014) Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS One 9: e97811.
109. Vercellotti, G.M. (1998) Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 9(Suppl. 2): S3-S6.
110. Vermeulen, M.W. and Gray, G.R. (1984) Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line. Infect Immun 46: 476-483.
111. Wang, P.L. and Ohura, K. (2002) Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med 13: 132-142.
112. Watanabe, T., Kitani, A., Murray, P.J. and Strober, W. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800-808.
113. Yavuzyilmaz, E., Yamalik, N., Bulut, S., Ozen, S., Ersoy, F. and Saatci, U. (1995) The gingival crevicular fluid interleukin-1 beta and tumour necrosis factor-alpha levels in patients with rapidly progressive periodontitis. Aust Dent J 40: 46-49.
114. Yuan, H., Zelka, S., Burkatovskaya, M., Gupte, R., Leeman, S.E. and Amar, S. (2013) Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci U S A 110: E5059-E5068.
115. Zhu, J., Quyyumi, A.A., Norman, J.E., Csako, G. and Epstein, S.E. (1999) Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 34: 1738-1743.
116. Zuany-Amorim, C., Hastewell, J. and Walker, C. (2002) Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov 1: 797-807.